PortfoliosLab logoPortfoliosLab logo
ABBV vs. T
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ABBV vs. T - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbbVie Inc. (ABBV) and AT&T Inc. (T). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ABBV achieves a 13.52% return, which is significantly higher than T's -7.04% return. Over the past 10 years, ABBV has outperformed T with an annualized return of 19.60%, while T has yielded a comparatively lower 2.10% annualized return.


ABBV

1D
-0.44%
1M
17.87%
6M
20.04%
YTD
13.52%
1Y
38.03%
3Y*
25.04%
5Y*
21.08%
10Y*
19.60%
ALL TIME*
20.49%

T

1D
0.64%
1M
2.62%
6M
-2.84%
YTD
-7.04%
1Y
-13.37%
3Y*
20.93%
5Y*
7.13%
10Y*
2.10%
ALL TIME*
9.35%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ABBV vs. T - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ABBV
AbbVie Inc.
13.52%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%
T
AT&T Inc.
-7.04%13.97%44.08%-2.74%5.76%-8.09%-21.37%45.55%-22.25%-4.01%

Correlation

The correlation between ABBV and T is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.23

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.28

Fundamentals

Market Cap

ABBV:

$447.67B

T:

$152.52B

EPS

ABBV:

$2.05

T:

$3.05

PE Ratio

ABBV:

123.48

T:

7.19

PS Ratio

ABBV:

7.15

T:

1.25

Total Revenue (TTM)

ABBV:

$62.82B

T:

$125.65B

Gross Profit (TTM)

ABBV:

$46.15B

T:

$105.41B

EBITDA (TTM)

ABBV:

$17.96B

T:

$54.70B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ABBV vs. T — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABBV
ABBV Risk / Return Rank: 8282
Overall Rank
ABBV Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 8383
Sortino Ratio Rank
ABBV Omega Ratio Rank: 8181
Omega Ratio Rank
ABBV Calmar Ratio Rank: 8181
Calmar Ratio Rank
ABBV Martin Ratio Rank: 7979
Martin Ratio Rank

T
T Risk / Return Rank: 2222
Overall Rank
T Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
T Sortino Ratio Rank: 1919
Sortino Ratio Rank
T Omega Ratio Rank: 2020
Omega Ratio Rank
T Calmar Ratio Rank: 2929
Calmar Ratio Rank
T Martin Ratio Rank: 2323
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABBV vs. T - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and AT&T Inc. (T). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ABBVTDifference
Sharpe ratioReturn per unit of total volatility

+2.04

Sortino ratioReturn per unit of downside risk

+2.86

Omega ratioGain probability vs. loss probability

1.27

0.92

+0.35

Calmar ratioReturn relative to maximum drawdown

2.21

-0.46

+2.67

Martin ratioReturn relative to average drawdown

4.89

-1.03

+5.92

ABBV vs. T - Sharpe Ratio Comparison

The current ABBV Sharpe Ratio is 1.47, which is higher than the T Sharpe Ratio of -0.57. The chart below compares the historical Sharpe Ratios of ABBV and T, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ABBV vs. T - Drawdown Comparison

The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum T drawdown of -64.15%. Use the drawdown chart below to compare losses from any high point for ABBV and T.


Loading charts...

Drawdown Indicators


ABBVTDifference

Max Drawdown

Largest peak-to-trough decline

-45.09%

-64.15%

+19.06%

Max Drawdown (1Y)

Largest decline over 1 year

-17.32%

-28.89%

+11.57%

Max Drawdown (3Y)

Largest decline over 3 years

-20.74%

-28.89%

+8.15%

Max Drawdown (5Y)

Largest decline over 5 years

-21.92%

-32.01%

+10.09%

Max Drawdown (10Y)

Largest decline over 10 years

-45.09%

-42.35%

-2.74%

Current Drawdown

Current decline from peak

-2.25%

-21.57%

+19.32%

Average Drawdown

Average peak-to-trough decline

-10.66%

-15.74%

+5.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.80%

12.94%

-5.14%

Volatility

ABBV vs. T - Volatility Comparison

AbbVie Inc. (ABBV) has a higher volatility of 10.69% compared to AT&T Inc. (T) at 9.59%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than T based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ABBVTDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.69%

9.59%

+1.10%

Volatility (6M)

Calculated over the trailing 6-month period

19.21%

19.91%

-0.70%

Volatility (1Y)

Calculated over the trailing 1-year period

26.01%

23.72%

+2.29%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

23.39%

24.38%

-0.99%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.90%

23.92%

+1.98%

Dividends

ABBV vs. T - Dividend Comparison

ABBV's dividend yield for the trailing twelve months is around 2.70%, less than T's 6.58% yield.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.70%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
T
AT&T Inc.
6.58%4.47%4.87%6.62%6.66%8.46%7.23%5.22%7.01%5.04%4.51%5.46%

Financials

ABBV vs. T - Financials Comparison

This section allows you to compare key financial metrics between AbbVie Inc. and AT&T Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


15.00B20.00B25.00B30.00B35.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
15.00B
33.47B
(ABBV) Total Revenue
(T) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ABBV and T have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ABBV has higher volatility (10.69%) compared to T (9.59%). In terms of maximum drawdown, ABBV dropped -45.09% vs T's -64.15%.

ABBV currently has the higher Sharpe Ratio (1.47 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ABBV and T

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer